VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $9,869,000 | -81.5% | 430,000 | -84.6% | 0.45% | -77.9% |
| Q2 2018 | $53,344,000 | +14.1% | 2,800,191 | +0.9% | 2.05% | -8.0% |
| Q1 2018 | $46,762,000 | +118.4% | 2,775,191 | +97.0% | 2.23% | +60.9% |
| Q4 2017 | $21,416,000 | +21.1% | 1,408,946 | +42.6% | 1.39% | +1.2% |
| Q3 2017 | $17,690,000 | +20.3% | 988,270 | +9.5% | 1.37% | -26.1% |
| Q2 2017 | $14,705,000 | +70.2% | 902,146 | +46.2% | 1.86% | +68.2% |
| Q1 2017 | $8,641,000 | +42.0% | 617,200 | +61.8% | 1.10% | -10.2% |
| Q4 2016 | $6,084,000 | -55.8% | 381,466 | -53.9% | 1.23% | -49.2% |
| Q3 2016 | $13,773,000 | +73.5% | 827,693 | +16.6% | 2.42% | +37.0% |
| Q2 2016 | $7,940,000 | +11.1% | 709,579 | -17.0% | 1.76% | -29.2% |
| Q1 2016 | $7,144,000 | -39.1% | 854,579 | -32.2% | 2.49% | -38.4% |
| Q4 2015 | $11,738,000 | -51.0% | 1,260,809 | -40.7% | 4.04% | -35.1% |
| Q3 2015 | $23,965,000 | +31.3% | 2,124,593 | +47.7% | 6.23% | +23.9% |
| Q2 2015 | $18,257,000 | – | 1,438,693 | – | 5.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |